These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 488666)

  • 41. Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver.
    Barter PJ; Nestel PJ; Carroll KF
    Metabolism; 1972 Feb; 21(2):117-24. PubMed ID: 5009387
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum and tissue lipid metabolism and effect of nicotinic acid in different types of hyperlipidemia.
    Carlson LA; Walldius G
    Adv Exp Med Biol; 1972; 26(0):165-78. PubMed ID: 4370366
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of diet on lipid metabolism in experimental animals and man.
    Herman RH; Zakim D; Stifel FB
    Fed Proc; 1970; 29(3):1302-7. PubMed ID: 4245709
    [No Abstract]   [Full Text] [Related]  

  • 44. Clofibrate and nicotinic acid.
    Hoffer A
    Can Med Assoc J; 1972 Sep; 107(6):488 passim. PubMed ID: 5057001
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
    Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Bieroń K; Kedzior A; Basista M; Zmuda A; Trabka E; Slawiński M; Czarnecka H
    Fortschr Med; 1989 Jul; 107(20):450-2. PubMed ID: 2767596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholesterol metabolism.
    Lancet; 1973 Mar; 1(7802):524-5. PubMed ID: 4119954
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of diet on lipid metabolism.
    Nutr Rev; 1971 Feb; 29(2):36-8. PubMed ID: 4938574
    [No Abstract]   [Full Text] [Related]  

  • 48. The treatment of hyperlipidemia.
    Lees RS; Wilson DE
    N Engl J Med; 1971 Jan; 284(4):186-95. PubMed ID: 4923684
    [No Abstract]   [Full Text] [Related]  

  • 49. The actions of clofibrate on hepatic metabolism in the rat.
    Laker ME; Mayes PA
    Biochem Soc Trans; 1976; 4(4):714-5. PubMed ID: 1001747
    [No Abstract]   [Full Text] [Related]  

  • 50. The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver.
    Laker ME; Mayes PA
    Biochem Pharmacol; 1979 Sep; 28(18):2813-27. PubMed ID: 497030
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
    Nordoy A; Gjone E
    Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
    [No Abstract]   [Full Text] [Related]  

  • 52. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
    Paul HS; Adibi SA
    J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.
    Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
    Hayashi E; Yamada J; Kunitomo M; Terada M; Tomita T; Kinoshita
    J Nutr Sci Vitaminol (Tokyo); 1976; 22(3):201-8. PubMed ID: 966076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lowering lipids rapidly and permanently with etofibrate].
    von Bock und Polach U
    Med Klin; 1982 Jan; 77(3):35-8. PubMed ID: 7057729
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of clofibrate on the plasma lipoprotein pattern and on the lipid content and protein and collagen synthesis in atherosclerotic coronary arteries and abdominal aorta from hypercholesterolemic mini-pigs.
    Jacobsson L
    Atherosclerosis; 1987 Feb; 63(2-3):173-80. PubMed ID: 3548736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypolipidemic drugs.
    Sirtori C; Fumagalli R; Paoletti R
    Adv Exp Med Biol; 1973; 38():171-98. PubMed ID: 4594063
    [No Abstract]   [Full Text] [Related]  

  • 59. [Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
    Pfeiffer M; Tilsner V
    Med Klin; 1978 Jan; 73(2):60-2. PubMed ID: 622057
    [No Abstract]   [Full Text] [Related]  

  • 60. Lipid lowering drugs and hyperlipidaemia.
    Levy RI; Rifking BM
    Drugs; 1973; 6(1):12-45. PubMed ID: 4361281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.